Patents by Inventor Michael Balamotis

Michael Balamotis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230417787
    Abstract: The present disclosure provides for processes and systems that rely on software, bioinformatics, and robotics principles for actuating the automation of a workflow from nucleic acid extraction from a sample to sequencing without human intervention in between the aforementioned steps.
    Type: Application
    Filed: June 23, 2023
    Publication date: December 28, 2023
    Inventors: Tiffany Cheung, Michael Balamotis, Werther Dong, Alfred Haddad, Prasanna Thwar
  • Publication number: 20230417786
    Abstract: The present disclosure provides for processes and systems that rely on software, bioinformatics, and robotics principles for actuating the automation of a workflow from nucleic acid extraction from a sample to sequencing without human intervention in between the aforementioned steps.
    Type: Application
    Filed: June 23, 2023
    Publication date: December 28, 2023
    Inventors: Tiffany Cheung, Michael Balamotis, Werther Dong, Alfred Haddad, Prasanna Thwar
  • Patent number: 10364470
    Abstract: The invention described in the application relates to a long non-coding RNA expressed in cancer. The invention thus provides methods and compositions for evaluating levels of the long non-coding RNA to assess the aggressiveness of a cancer and for modulating levels of the long non-coding RNA.
    Type: Grant
    Filed: November 16, 2016
    Date of Patent: July 30, 2019
    Assignee: The Regents of the University of California
    Inventors: Terumi Kohwi-Shigematsu, Yoshinori Kohwi, Ellen C. Ordinario, Michael A. Balamotis, Hye-Jung Han
  • Publication number: 20170067125
    Abstract: The invention described in the application relates to a long non-coding RNA expressed in cancer. The invention thus provides methods and compositions for evaluating levels of the long non-coding RNA to assess the aggressiveness of a cancer and for modulating levels of the long non-coding RNA.
    Type: Application
    Filed: November 16, 2016
    Publication date: March 9, 2017
    Inventors: Terumi Kohwi-Shigematsu, Yoshinori Kohwi, Ellen C. Ordinario, Michael A. Balamotis, Hye-Jung Han